Novo Nordisk | NVO - Assets

Stock Price
37.61
Daily Change
0.70 1.90%
Monthly
-5.43%
Yearly
-42.25%
Q2 Forecast
35.05

Novo Nordisk reported DKK76.18B in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
ANI Pharmaceuticals USD 1.44B 32.22M Dec/2025
Aurora Cannabis CAD 775.29M 18.43M Dec/2025
Bausch Health Companies USD 26.37B 458M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Canopy Growth CAD 1.11B 36.35M Dec/2025
Corcept Therapeutics USD 836.65M 13.04M Dec/2025
Drreddys Laboratories INR 6.26B 161.9M Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Merck USD 129.55B 12.02B Sep/2025
Nektar Therapeutics USD 280.41M 20.94M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Novo Nordisk DKK 542.9B 30.61B Dec/2025
Novo Nordisk DKK 76.18B 412.98B Jun/2025
Pacira USD 1.26B 32.66M Dec/2025
Perrigo USD 8.54B 1.55B Dec/2025
Phibro Animal Health USD 1.41B 20.03M Dec/2025
Prestige Brands USD 3.49B 52.46M Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Supernus Pharmaceuticals USD 1.45B 32.89M Dec/2025
Zoetis USD 15.47B 308M Dec/2025